PPARG and Other metabolic disease: Finally, MAFLD-related metabolic disorders, such as insulin resistance, diminish HBV replication by suppressing the activity of peroxisome proliferator-activated receptor-gamma (PPAR-γ) coactivator one alpha [21, 22].